IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RA Capital Management, L.P.

Q3 2018 Holdings

Filed 2018-11-14 | 26 holdings | $474.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ascendis Pharma A S(ASND)SPONSORED ADR04351P101$300.5M4,240,53663.4%
Biocryst Pharmaceuticals(BCRX)COM09058V103$70.5M9,234,69214.9%
Arvinas Inc(ARVN)COM04335A105$52.9M3,138,41211.2%
Crinetics Pharmaceuticals Inc(CRNX)COM22663K107$48.7M1,701,01710.3%
Wave Life Sciences LTD(WVE)SHSY95308105$375.6K7,512,0490.1%
Solid Biosciences IncCOM83422E105$126.9K2,689,4440.0%
Endocyte IncCOM29269A102$110.0K6,196,1430.0%
Zogenix IncCOM NEW98978L204$93.2K1,878,7680.0%
Myovant Sciences LTDCOMG637AM102$91.6K3,451,8590.0%
RA Pharmaceuticals IncCOM74933V108$69.7K3,851,8080.0%
Inflarx NV(IFRX)COMN44821101$67.5K1,967,8480.0%
Immunomedics Inc(IMMU)COM452907108$65.0K3,119,7780.0%
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$60.0K3,933,4890.0%
Rhythm Pharmaceuticals Inc(RYTM)COM76243J105$56.9K1,950,3320.0%
Sage Therapeutics Inc(SG7)COM78667J108$49.6K350,9330.0%
TG Therapeutics Inc(TGTX)COM88322Q108$45.9K8,198,3370.0%
Momenta Pharmaceuticals Inc(MNTA)COM60877T100$41.0K1,558,3570.0%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$31.9K1,441,0700.0%
Eidos Therapeutics Inc(EIDXGBP)COM28249H104$21.6K2,162,6710.0%
Kala Pharmaceuticals IncCOM483119103$20.9K2,113,2360.0%
Progenics Pharmaceuticals IncCOM743187106$19.0K3,030,3030.0%
Scpharmaceuticals Inc(SCPH)COM810648105$16.8K2,857,1430.0%
Apellis Pharmaceuticals Inc(APLS)COM03753U106$16.0K900,0000.0%
Iovance Biotherapeutics Inc(IOVA)COM462260100$12.6K1,121,1530.0%
Glycomimetics Inc(GLYCEUR)COM38000Q102$3.7K253,5470.0%
Proteon Therapeutics IncCOM74371L109$2.6K1,337,4620.0%